{"DataElement":{"publicId":"3370583","version":"1","preferredName":"Patient Ineligibility Reason","preferredDefinition":"The explanation of why a participant is declared ineligible for a clinical trial.","longName":"PT_INELIG_Rsn","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"2015056","version":"1","preferredName":"Patient Ineligibility","preferredDefinition":"the patient's status as ineligible to participate in the study.","longName":"PT_INELIG","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177068","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"Patient","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7AB6-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2188655","version":"1","preferredName":"Ineligibility","preferredDefinition":"The state or quality of being disqualified by law, rule, or provision.","longName":"Ineligibility","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Ineligibility","conceptCode":"C40412","definition":"The state or quality of being disqualified by law, rule, or provision.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E52C0FF9-FAD4-30E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-09-28","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":"Requested by Brian Campbell","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C9D607F4-0F68-2283-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-10-01","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3370577","version":"1","preferredName":"Ineligibility Reason","preferredDefinition":"The explanation of why a participant is declared ineligible for a clinical trial.","longName":"Inelig_Rsn","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"255","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2991873","version":"1","preferredName":"Other","longName":"2991873","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7DC8B94A-9F2D-1457-E040-BB89AD430D33","latestVersionIndicator":"Yes","beginDate":"2010-01-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2010-01-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  WZhang, 02/23/2015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B92D09CE-5813-6CE0-E040-BB89AD435524","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"ONEDATA","dateModified":"2012-02-17","deletedIndicator":"No"},{"value":"Timing of start of protocol therapy","valueDescription":"Timing of start of protocol therapy","ValueMeaning":{"publicId":"3379593","version":"1","preferredName":"Timing of start of protocol therapy","longName":"3379593","preferredDefinition":"Timing of start of protocol therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B92D09CE-581D-6CE0-E040-BB89AD435524","latestVersionIndicator":"Yes","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B92D09CE-5836-6CE0-E040-BB89AD435524","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"ONEDATA","dateModified":"2012-02-17","deletedIndicator":"No"},{"value":"Timing of enrollment","valueDescription":"Timing of enrollment","ValueMeaning":{"publicId":"3379594","version":"1","preferredName":"Timing of enrollment","longName":"3379594","preferredDefinition":"Timing of enrollment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B92D09CE-5840-6CE0-E040-BB89AD435524","latestVersionIndicator":"Yes","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B92D09CE-5859-6CE0-E040-BB89AD435524","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"ONEDATA","dateModified":"2012-02-17","deletedIndicator":"No"},{"value":"Stage, extent of disease","valueDescription":"Stage, extent of disease","ValueMeaning":{"publicId":"3379595","version":"1","preferredName":"Stage, extent of disease","longName":"3379595","preferredDefinition":"Stage, extent of disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B92D09CE-5863-6CE0-E040-BB89AD435524","latestVersionIndicator":"Yes","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B92D09CE-587C-6CE0-E040-BB89AD435524","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"ONEDATA","dateModified":"2012-02-17","deletedIndicator":"No"},{"value":"Prior therapy","valueDescription":"Prior Therapy","ValueMeaning":{"publicId":"2562206","version":"1","preferredName":"Prior Therapy","longName":"2562206","preferredDefinition":"Prior Therapy","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior Therapy","conceptCode":"C16124","definition":"Prior action or administration of therapeutic agents that produced an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C00B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-02","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B92D09CE-5890-6CE0-E040-BB89AD435524","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"ONEDATA","dateModified":"2012-02-17","deletedIndicator":"No"},{"value":"Patient characteristics","valueDescription":"Patient characteristics","ValueMeaning":{"publicId":"3379596","version":"1","preferredName":"Patient characteristics","longName":"3379596","preferredDefinition":"Patient characteristics (e.g., age,  performance status, etc.)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B92D09CE-589B-6CE0-E040-BB89AD435524","latestVersionIndicator":"Yes","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B92D09CE-58B4-6CE0-E040-BB89AD435524","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"ONEDATA","dateModified":"2012-02-17","deletedIndicator":"No"},{"value":"Organ function requirements","valueDescription":"Organ function requirements","ValueMeaning":{"publicId":"3379597","version":"1","preferredName":"Organ function requirements","longName":"3379597","preferredDefinition":"Organ function requirements","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B92D09CE-58BE-6CE0-E040-BB89AD435524","latestVersionIndicator":"Yes","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B92D09CE-58D7-6CE0-E040-BB89AD435524","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"ONEDATA","dateModified":"2012-02-17","deletedIndicator":"No"},{"value":"Disease type or histology","valueDescription":"Disease type or histology","ValueMeaning":{"publicId":"3379598","version":"1","preferredName":"Disease type or histology","longName":"3379598","preferredDefinition":"Disease type or histology","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B92D09CE-58E1-6CE0-E040-BB89AD435524","latestVersionIndicator":"Yes","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B92D09CE-58FA-6CE0-E040-BB89AD435524","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"ONEDATA","dateModified":"2012-02-17","deletedIndicator":"No"},{"value":"Required specimens not submitted per protocol","valueDescription":"Required specimens not submitted per protocol","ValueMeaning":{"publicId":"4207351","version":"1","preferredName":"Required specimens not submitted per protocol","longName":"4207351","preferredDefinition":"Required specimens not submitted per protocol","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F447658F-A8FF-F295-E040-BB89AD437C58","latestVersionIndicator":"Yes","beginDate":"2014-03-10","endDate":null,"createdBy":"WONGW","dateCreated":"2014-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F447658F-A918-F295-E040-BB89AD437C58","beginDate":"2014-03-10","endDate":null,"createdBy":"WONGW","dateCreated":"2014-03-10","modifiedBy":"ONEDATA","dateModified":"2014-03-10","deletedIndicator":"No"},{"value":"Tumor Genomic features","valueDescription":"Tumor Genomic features","ValueMeaning":{"publicId":"4351871","version":"1","preferredName":"Tumor Genomic features","longName":"4351871","preferredDefinition":"Tumor Genomic features","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB09EF45-F0A8-D4DA-E040-BB89AD4366BA","latestVersionIndicator":"Yes","beginDate":"2014-06-04","endDate":null,"createdBy":"TSANE","dateCreated":"2014-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB09EF45-F0C1-D4DA-E040-BB89AD4366BA","beginDate":"2014-06-04","endDate":null,"createdBy":"TSANE","dateCreated":"2014-06-04","modifiedBy":"ONEDATA","dateModified":"2014-06-04","deletedIndicator":"No"},{"value":"Metastatic disease","valueDescription":"Metastatic disease","ValueMeaning":{"publicId":"5162073","version":"1","preferredName":"Metastatic disease","longName":"5162073","preferredDefinition":"Metastatic disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E312121-A353-1F0E-E050-BB89AD430502","latestVersionIndicator":"Yes","beginDate":"2016-03-16","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-03-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3230845D-2FD6-4988-E050-BB89AD435EFB","beginDate":"2016-05-06","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-06","modifiedBy":"ONEDATA","dateModified":"2016-05-06","deletedIndicator":"No"},{"value":">1.5cm2 residual disease","valueDescription":">1.5cm2 residual disease","ValueMeaning":{"publicId":"5254473","version":"1","preferredName":">1.5cm2 residual disease","longName":"5254473","preferredDefinition":">1.5cm2 residual disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3230845D-2FE0-4988-E050-BB89AD435EFB","latestVersionIndicator":"Yes","beginDate":"2016-05-06","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3230845D-2FF9-4988-E050-BB89AD435EFB","beginDate":"2016-05-06","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-06","modifiedBy":"ONEDATA","dateModified":"2016-05-06","deletedIndicator":"No"},{"value":"Negative for CTNNB1 mutation","valueDescription":"Negative for CTNNB1 mutation","ValueMeaning":{"publicId":"5254474","version":"1","preferredName":"Negative for CTNNB1 mutation","longName":"5254474","preferredDefinition":"Negative for CTNNB1 mutation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3230845D-3003-4988-E050-BB89AD435EFB","latestVersionIndicator":"Yes","beginDate":"2016-05-06","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3230845D-301C-4988-E050-BB89AD435EFB","beginDate":"2016-05-06","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-06","modifiedBy":"ONEDATA","dateModified":"2016-05-06","deletedIndicator":"No"},{"value":"Large cell/Anaplastic","valueDescription":"Large cell/Anaplastic","ValueMeaning":{"publicId":"5254475","version":"1","preferredName":"Large cell/Anaplastic","longName":"5254475","preferredDefinition":"Large cell/Anaplastic","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3230845D-3026-4988-E050-BB89AD435EFB","latestVersionIndicator":"Yes","beginDate":"2016-05-06","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3230845D-303F-4988-E050-BB89AD435EFB","beginDate":"2016-05-06","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-06","modifiedBy":"ONEDATA","dateModified":"2016-05-06","deletedIndicator":"No"},{"value":"MYC or MYCN amplified","valueDescription":"MYC or MYCN amplified","ValueMeaning":{"publicId":"5254476","version":"1","preferredName":"MYC or MYCN amplified","longName":"5254476","preferredDefinition":"MYC or MYCN amplified","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3230845D-3049-4988-E050-BB89AD435EFB","latestVersionIndicator":"Yes","beginDate":"2016-05-06","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3230845D-3062-4988-E050-BB89AD435EFB","beginDate":"2016-05-06","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-06","modifiedBy":"ONEDATA","dateModified":"2016-05-06","deletedIndicator":"No"},{"value":"Negative for beta-catenin","valueDescription":"Negative for beta-catenin","ValueMeaning":{"publicId":"5254477","version":"1","preferredName":"Negative for beta-catenin","longName":"5254477","preferredDefinition":"Negative for beta-catenin","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3230845D-306C-4988-E050-BB89AD435EFB","latestVersionIndicator":"Yes","beginDate":"2016-05-06","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3230845D-3085-4988-E050-BB89AD435EFB","beginDate":"2016-05-06","endDate":null,"createdBy":"HAMMA","dateCreated":"2016-05-06","modifiedBy":"ONEDATA","dateModified":"2016-05-06","deletedIndicator":"No"},{"value":"Major surgery or procedure within 7 days of starting protocol therapy","valueDescription":"Major surgery or procedure within 7 days of starting protocol therapy","ValueMeaning":{"publicId":"6383922","version":"1","preferredName":"Major surgery or procedure within 7 days of starting protocol therapy","longName":"6383922","preferredDefinition":"Major surgery or procedure within 7 days of starting protocol therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"728E5795-4C23-0A75-E053-F662850A774B","latestVersionIndicator":"Yes","beginDate":"2018-08-03","endDate":null,"createdBy":"TANGL","dateCreated":"2018-08-03","modifiedBy":"ONEDATA","dateModified":"2018-08-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"728E5795-4C3C-0A75-E053-F662850A774B","beginDate":"2018-08-03","endDate":null,"createdBy":"TANGL","dateCreated":"2018-08-03","modifiedBy":"ONEDATA","dateModified":"2018-08-03","deletedIndicator":"No"},{"value":"Patient has cognitive inability to complete instruments according to the primary team","valueDescription":"Patient has cognitive inability to complete instruments according to the primary team","ValueMeaning":{"publicId":"6564254","version":"1","preferredName":"Patient has cognitive inability to complete instruments according to the primary team","longName":"6564254","preferredDefinition":"Patient has cognitive inability to complete instruments according to the primary team","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B1E12A4-FAD9-4525-E053-F662850ABF6C","latestVersionIndicator":"Yes","beginDate":"2018-11-20","endDate":null,"createdBy":"LEEW","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7B1E12A4-FAF2-4525-E053-F662850ABF6C","beginDate":"2018-11-20","endDate":null,"createdBy":"LEEW","dateCreated":"2018-11-20","modifiedBy":"ONEDATA","dateModified":"2018-11-20","deletedIndicator":"No"},{"value":"Patient has known history of neurodevelopmental disorder prior to diagnosis of CML (e.g., Down syndrome, Fragile X, William syndrome, mental retardation)","valueDescription":"Patient has known history of neurodevelopmental disorder prior to diagnosis of CML (e.g., Down syndrome, Fragile X, William syndrome, mental retardation)","ValueMeaning":{"publicId":"6548604","version":"1","preferredName":"Patient has known history of neurodevelopmental disorder prior to diagnosis of CML (e.g., Down syndrome, Fragile X, William syndrome, mental retardation)","longName":"6548604","preferredDefinition":"Patient has known history of neurodevelopmental disorder prior to diagnosis of CML (e.g., Down syndrome, Fragile X, William syndrome, mental retardation)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A0553BC-0203-6B79-E053-F662850A64E0","latestVersionIndicator":"Yes","beginDate":"2018-11-06","endDate":null,"createdBy":"LEEW","dateCreated":"2018-11-06","modifiedBy":"ONEDATA","dateModified":"2018-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A0553BC-021C-6B79-E053-F662850A64E0","beginDate":"2018-11-06","endDate":null,"createdBy":"LEEW","dateCreated":"2018-11-06","modifiedBy":"ONEDATA","dateModified":"2018-11-06","deletedIndicator":"No"},{"value":"Patient has significant visual or motor impairment that would prevent computer use or recognition of visual test stimuli","valueDescription":"Patient has significant visual or motor impairment that would prevent computer use or recognition of visual test stimuli","ValueMeaning":{"publicId":"6548603","version":"1","preferredName":"Patient has significant visual or motor impairment that would prevent computer use or recognition of visual test stimuli","longName":"6548603","preferredDefinition":"Patient has significant visual or motor impairment that would prevent computer use or recognition of visual test stimuli","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A0553BC-01E0-6B79-E053-F662850A64E0","latestVersionIndicator":"Yes","beginDate":"2018-11-06","endDate":null,"createdBy":"LEEW","dateCreated":"2018-11-06","modifiedBy":"ONEDATA","dateModified":"2018-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A0553BC-01F9-6B79-E053-F662850A64E0","beginDate":"2018-11-06","endDate":null,"createdBy":"LEEW","dateCreated":"2018-11-06","modifiedBy":"ONEDATA","dateModified":"2018-11-06","deletedIndicator":"No"},{"value":"Patient is not English, French or Spanish speaking","valueDescription":"Patient is not English, French or Spanish speaking","ValueMeaning":{"publicId":"6548605","version":"1","preferredName":"Patient is not English, French or Spanish speaking","longName":"6548605","preferredDefinition":"Patient is not English, French or Spanish speaking","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A0553BC-0226-6B79-E053-F662850A64E0","latestVersionIndicator":"Yes","beginDate":"2018-11-06","endDate":null,"createdBy":"LEEW","dateCreated":"2018-11-06","modifiedBy":"ONEDATA","dateModified":"2018-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A0553BC-023F-6B79-E053-F662850A64E0","beginDate":"2018-11-06","endDate":null,"createdBy":"LEEW","dateCreated":"2018-11-06","modifiedBy":"ONEDATA","dateModified":"2018-11-06","deletedIndicator":"No"},{"value":"Patient is not 5 years or older at the time of enrollment","valueDescription":"Patient is not 5 years or older at the time of enrollment","ValueMeaning":{"publicId":"6548606","version":"1","preferredName":"Patient is not 5 years or older at the time of enrollment","longName":"6548606","preferredDefinition":"Patient is not 5 years or older at the time of enrollment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A0553BC-0249-6B79-E053-F662850A64E0","latestVersionIndicator":"Yes","beginDate":"2018-11-06","endDate":null,"createdBy":"LEEW","dateCreated":"2018-11-06","modifiedBy":"ONEDATA","dateModified":"2018-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A0553BC-0262-6B79-E053-F662850A64E0","beginDate":"2018-11-06","endDate":null,"createdBy":"LEEW","dateCreated":"2018-11-06","modifiedBy":"ONEDATA","dateModified":"2018-11-06","deletedIndicator":"No"},{"value":"Patient does not understand English or Spanish","valueDescription":"Patient does not understand English or Spanish","ValueMeaning":{"publicId":"6548608","version":"1","preferredName":"Patient does not understand English or Spanish","longName":"6548608","preferredDefinition":"Patient does not understand English or Spanish","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A0553BC-028F-6B79-E053-F662850A64E0","latestVersionIndicator":"Yes","beginDate":"2018-11-06","endDate":null,"createdBy":"LEEW","dateCreated":"2018-11-06","modifiedBy":"ONEDATA","dateModified":"2018-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A0553BC-02A8-6B79-E053-F662850A64E0","beginDate":"2018-11-06","endDate":null,"createdBy":"LEEW","dateCreated":"2018-11-06","modifiedBy":"ONEDATA","dateModified":"2018-11-06","deletedIndicator":"No"},{"value":"Patient is not 8 years or older at time of enrollment","valueDescription":"Patient is not 8 years or older at time of enrollment","ValueMeaning":{"publicId":"6548609","version":"1","preferredName":"Patient is not 8 years or older at time of enrollment","longName":"6548609","preferredDefinition":"Patient is not 8 years or older at time of enrollment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A0553BC-02B2-6B79-E053-F662850A64E0","latestVersionIndicator":"Yes","beginDate":"2018-11-06","endDate":null,"createdBy":"LEEW","dateCreated":"2018-11-06","modifiedBy":"ONEDATA","dateModified":"2018-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A0553BC-02CB-6B79-E053-F662850A64E0","beginDate":"2018-11-06","endDate":null,"createdBy":"LEEW","dateCreated":"2018-11-06","modifiedBy":"ONEDATA","dateModified":"2018-11-06","deletedIndicator":"No"},{"value":"Assay failure","valueDescription":"Bioassay Indeterminate Value","ValueMeaning":{"publicId":"6600852","version":"1","preferredName":"Bioassay Indeterminate Value","longName":"6600852","preferredDefinition":"A laboratory test or analysis of the biological activity of a substance performed by studying its effect on an organism or in a test tube under controlled conditions.: Cannot distinguish between two or more possible values in the current context.: A numerical quantity measured or assigned or computed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bioassay","conceptCode":"C16341","definition":"A laboratory test or analysis of the biological activity of a substance performed by studying its effect on an organism or in a test tube under controlled conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E1A84C4-853F-488B-E053-F662850AA6CF","latestVersionIndicator":"Yes","beginDate":"2018-12-28","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2018-12-28","modifiedBy":"ONEDATA","dateModified":"2018-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7E1A84C4-8558-488B-E053-F662850AA6CF","beginDate":"2018-12-28","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2018-12-28","modifiedBy":"ONEDATA","dateModified":"2018-12-28","deletedIndicator":"No"},{"value":"Repeat eligibility studies are outside the parameters required for eligibility","valueDescription":"Repeat eligibility studies are outside the parameters required for eligibility","ValueMeaning":{"publicId":"5083512","version":"1","preferredName":"Repeat eligibility studies are outside the parameters required for eligibility","longName":"5083512","preferredDefinition":"Repeat eligibility studies are outside the parameters required for eligibility","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"26826FC3-5DD9-AEA2-E050-BB89AD433D3A","latestVersionIndicator":"Yes","beginDate":"2015-12-09","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-12-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FAF3F40-1EC0-0B2D-E053-F662850A69E0","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","deletedIndicator":"No"},{"value":"Patient characteristics (e.g., age, performance status, etc.)","valueDescription":"Patient characteristics","ValueMeaning":{"publicId":"3379596","version":"1","preferredName":"Patient characteristics","longName":"3379596","preferredDefinition":"Patient characteristics (e.g., age,  performance status, etc.)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B92D09CE-589B-6CE0-E040-BB89AD435524","latestVersionIndicator":"Yes","beginDate":"2012-02-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BC0852D-4969-7E1B-E053-F662850A8E0C","beginDate":"2018-11-28","endDate":null,"createdBy":"LEEW","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"Informed Consent","valueDescription":"Informed Consent","ValueMeaning":{"publicId":"2857225","version":"1","preferredName":"Informed Consent","longName":"2857225","preferredDefinition":"Consent by a patient to a surgical or medical procedure or participation in a clinical study after achieving an understanding of the relevant medical facts and the risks involved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Informed Consent","conceptCode":"C16735","definition":"Consent by a patient to a surgical or medical procedure or participation in a clinical study after achieving an understanding of the relevant medical facts and the risks involved.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"661EB49B-B53F-7D2B-E040-BB89AD4340DC","latestVersionIndicator":"Yes","beginDate":"2009-03-27","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-03-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8631A12A-474C-62B4-E053-F662850A2667","beginDate":"2019-04-10","endDate":null,"createdBy":"SHOARYAS","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"Exclusion Criteria","valueDescription":"Exclusion Criteria","ValueMeaning":{"publicId":"2572497","version":"1","preferredName":"Exclusion Criteria","longName":"2572497","preferredDefinition":"Exclusion Criteria","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E83E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-12-21","modifiedBy":"MAESKEB","dateModified":"2004-12-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8631A12A-4760-62B4-E053-F662850A2667","beginDate":"2019-04-10","endDate":null,"createdBy":"SHOARYAS","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"Performance Level","valueDescription":"Performance Level","ValueMeaning":{"publicId":"6689549","version":"1","preferredName":"Performance Level","longName":"6689549","preferredDefinition":"Performance Level","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8631A12A-476A-62B4-E053-F662850A2667","latestVersionIndicator":"Yes","beginDate":"2019-04-10","endDate":null,"createdBy":"SHOARYAS","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8631A12A-4783-62B4-E053-F662850A2667","beginDate":"2019-04-10","endDate":null,"createdBy":"SHOARYAS","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"Disease Status","valueDescription":"Disease Status","ValueMeaning":{"publicId":"6689550","version":"1","preferredName":"Disease Status","longName":"6689550","preferredDefinition":"Disease Status","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8631A12A-478D-62B4-E053-F662850A2667","latestVersionIndicator":"Yes","beginDate":"2019-04-10","endDate":null,"createdBy":"SHOARYAS","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8631A12A-47A6-62B4-E053-F662850A2667","beginDate":"2019-04-10","endDate":null,"createdBy":"SHOARYAS","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"Diagnosis","valueDescription":"Diagnosis","ValueMeaning":{"publicId":"5188351","version":"1","preferredName":"Diagnosis","longName":"5188351","preferredDefinition":"Diagnosis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E93305E-3C92-2735-E050-BB89AD435006","latestVersionIndicator":"Yes","beginDate":"2016-03-21","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-03-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8631A12A-47B0-62B4-E053-F662850A2667","beginDate":"2019-04-10","endDate":null,"createdBy":"SHOARYAS","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"Age","valueDescription":"Age","ValueMeaning":{"publicId":"2815178","version":"1","preferredName":"Age","longName":"2815178","preferredDefinition":"A period or stage in life, usually stated in years since birth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Age","conceptCode":"C25150","definition":"How long something has existed; elapsed time since birth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5DCAAC7C-6786-4858-E040-BB89A6432A2D","latestVersionIndicator":"Yes","beginDate":"2008-12-11","endDate":null,"createdBy":"LEEB","dateCreated":"2008-12-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8631A12A-47BA-62B4-E053-F662850A2667","beginDate":"2019-04-10","endDate":null,"createdBy":"SHOARYAS","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"Timing","valueDescription":"Timing","ValueMeaning":{"publicId":"4903764","version":"1","preferredName":"Timing","longName":"4903764","preferredDefinition":"The chronological relationship between temporal events.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Timing","conceptCode":"C80484","definition":"The chronological relationship between temporal events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B16B1A7-0549-15A5-E050-BB89AD436F4F","latestVersionIndicator":"Yes","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8631A12A-47C4-62B4-E053-F662850A2667","beginDate":"2019-04-10","endDate":null,"createdBy":"SHOARYAS","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"Allergy to Related Drugs","valueDescription":"Allergy to Related Drugs","ValueMeaning":{"publicId":"7012187","version":"1","preferredName":"Allergy to Related Drugs","longName":"7012187","preferredDefinition":"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.: Used as a function word to indicate direction, purpose, or movement.: A state of connectedness between people, objects, or events; to be associated or connected with something.: A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Allergic Reaction","conceptCode":"C114476","definition":"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Medication","conceptCode":"C459","definition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95828E02-5ABB-37D3-E053-F662850AC689","latestVersionIndicator":"Yes","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"MAESKEB","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95828E02-5AD4-37D3-E053-F662850AC689","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Eligibility Procedure Timing","valueDescription":"Eligibility Intervention or Procedure Timing","ValueMeaning":{"publicId":"7012228","version":"1","preferredName":"Eligibility Intervention or Procedure Timing","longName":"7012228","preferredDefinition":"Satisfying the appropriate conditions for inclusion.: An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.: The chronological relationship between temporal events.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Eligible","conceptCode":"C126586","definition":"Satisfying the appropriate conditions for inclusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Intervention or Procedure","conceptCode":"C25218","definition":"An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Timing","conceptCode":"C80484","definition":"The chronological relationship between temporal events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95828E02-5AE9-37D3-E053-F662850AC689","latestVersionIndicator":"Yes","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"MAESKEB","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95828E02-5B02-37D3-E053-F662850AC689","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Comorbidity/Medical History","valueDescription":"Comorbidity Personal Medical History","ValueMeaning":{"publicId":"7012229","version":"1","preferredName":"Comorbidity Personal Medical History","longName":"7012229","preferredDefinition":"The coexistence of two or more disease processes.: A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Comorbidity","conceptCode":"C16457","definition":"The coexistence of two or more disease processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Personal Medical History","conceptCode":"C18772","definition":"A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95828E02-5B0F-37D3-E053-F662850AC689","latestVersionIndicator":"Yes","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95828E02-5B28-37D3-E053-F662850AC689","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Surgery Timing","valueDescription":"Surgery Timing","ValueMeaning":{"publicId":"7013120","version":"1","preferredName":"Surgery Timing","longName":"7013120","preferredDefinition":"The branch of medical science that treats disease or injury by operative procedures.: The chronological relationship between temporal events.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgery","conceptCode":"C17173","definition":"The branch of medical science that treats disease or injury by operative procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Timing","conceptCode":"C80484","definition":"The chronological relationship between temporal events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9583A5E8-64E9-0C9A-E053-F662850AD408","latestVersionIndicator":"Yes","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9583A5E8-6502-0C9A-E053-F662850AD408","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Protocol Eligibility Criterion NOT Listed Above","valueDescription":"Protocol Eligibility Criterion NOT Listed Above","ValueMeaning":{"publicId":"7013121","version":"1","preferredName":"Protocol Eligibility Criterion NOT Listed Above","longName":"7013121","preferredDefinition":"Protocol Eligibility Criterion NOT Listed Above","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9583A5E8-650C-0C9A-E053-F662850AD408","latestVersionIndicator":"Yes","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9583A5E8-6525-0C9A-E053-F662850AD408","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Prohibited Concomitant Medication","valueDescription":"Prohibited Concomitant Medication","ValueMeaning":{"publicId":"7013122","version":"1","preferredName":"Prohibited Concomitant Medication","longName":"7013122","preferredDefinition":"Prohibited Concomitant Medication","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9583A5E8-652F-0C9A-E053-F662850AD408","latestVersionIndicator":"Yes","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9583A5E8-6548-0C9A-E053-F662850AD408","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Prior Cancer","valueDescription":"Prior Malignant Neoplasm","ValueMeaning":{"publicId":"2774527","version":"1","preferredName":"Prior Malignant Neoplasm","longName":"2774527","preferredDefinition":"Earlier in time or order.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"545BF7ED-22A1-164E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9583A5E8-655C-0C9A-E053-F662850AD408","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Pregnancy-Related Issue","valueDescription":"Pregnancy Related Issue","ValueMeaning":{"publicId":"7013118","version":"1","preferredName":"Pregnancy Related Issue","longName":"7013118","preferredDefinition":"The state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth.: A state of connectedness between people, objects, or events; to be associated or connected with something.: One of a series of documents that are published periodically.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pregnancy","conceptCode":"C25742","definition":"The state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Issue","conceptCode":"C43415","definition":"One of a series of documents that are published periodically.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95836712-F5FA-37D9-E053-F662850A3E3F","latestVersionIndicator":"Yes","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"MAESKEB","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95836712-F613-37D9-E053-F662850A3E3F","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"PI Decision","valueDescription":"PI Discretion","ValueMeaning":{"publicId":"2578133","version":"1","preferredName":"PI Discretion","longName":"2578133","preferredDefinition":"An investigator who is responsible for all aspects of the conduct of a study.: A position, opinion, or judgment reached on an issue under consideration.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Principal Investigator","conceptCode":"C19924","definition":"An investigator who is responsible for all aspects of the conduct of a study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Decision","conceptCode":"C53285","definition":"A position, opinion, or judgment reached on an issue under consideration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FE42-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-13","modifiedBy":"REEVESD","dateModified":"2016-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95836712-F627-37D9-E053-F662850A3E3F","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Lack of Targeted Disease, Pathology or Biomarker","valueDescription":"Lack of Targeted Disease, Pathology or Biomarker","ValueMeaning":{"publicId":"7013119","version":"1","preferredName":"Lack of Targeted Disease, Pathology or Biomarker","longName":"7013119","preferredDefinition":"Lack of Targeted Disease, Pathology or Biomarker","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95836712-F632-37D9-E053-F662850A3E3F","latestVersionIndicator":"Yes","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95836712-F64B-37D9-E053-F662850A3E3F","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Lab Values","valueDescription":"Laboratory Values","ValueMeaning":{"publicId":"7013116","version":"1","preferredName":"Laboratory Values","longName":"7013116","preferredDefinition":"A facility equipped and competent to conduct scientific experiments, observations, tests, investigations, and/or to manufacture chemicals or medical products.: A numerical quantity measured or assigned or computed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory","conceptCode":"C37984","definition":"A facility equipped and competent to conduct scientific experiments, observations, tests, investigations, and/or to manufacture chemicals or medical products.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9583856B-588F-6E03-E053-F662850AB24A","latestVersionIndicator":"Yes","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"MAESKEB","dateModified":"2019-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9583856B-58A8-6E03-E053-F662850AB24A","beginDate":"2019-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-22","modifiedBy":"ONEDATA","dateModified":"2019-10-22","deletedIndicator":"No"},{"value":"Group 3 with isochromosome 17q","valueDescription":"Medulloblastoma Group Three With Isochromosome 17q","ValueMeaning":{"publicId":"7992774","version":"1","preferredName":"Medulloblastoma Group Three With Isochromosome 17q","longName":"7992774","preferredDefinition":"A malignant, invasive embryonal neoplasm arising from the cerebellum or posterior fossa. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: classic medulloblastoma, large cell/anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, and medulloblastoma with extensive nodularity.: Any number of entities (members) considered as a unit.: A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.: Used to indicate the presence of something or someone.: Metacentric chromosomes produced during MEIOSIS or MITOSIS when the CENTROMERE splits transversely instead of longitudinally. The chromosomes produced by this abnormal division are one chromosome having the two long arms of the original chromosome, but no short arms, and the other chromosome consisting of the two short arms and no long arms. Each of these isochromosomes constitutes a simultaneous duplication and deletion.: Distal (long) arm of chromosome 17","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medulloblastoma","conceptCode":"C3222","definition":"A malignant, invasive embryonal neoplasm arising from the cerebellum or posterior fossa. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: classic medulloblastoma, large cell/anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, and medulloblastoma with extensive nodularity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Group","conceptCode":"C43359","definition":"Any number of entities (members) considered as a unit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Three","conceptCode":"C66834","definition":"A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Isochromosome","conceptCode":"C3897","definition":"An abnormal chromosome with identical arms, formed by transverse splitting of the centromere during chromosomal replication.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"17q","conceptCode":"C13543","definition":"Distal (long) arm of chromosome 17","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4293EA1-55D7-0EBF-E053-4EBD850A1329","latestVersionIndicator":"Yes","beginDate":"2021-12-27","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-12-27","modifiedBy":"ONEDATA","dateModified":"2021-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4293EA1-55F0-0EBF-E053-4EBD850A1329","beginDate":"2021-12-27","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-12-27","modifiedBy":"ONEDATA","dateModified":"2021-12-27","deletedIndicator":"No"},{"value":"SHH with chromosome 14q loss","valueDescription":"Sonic Hedgehog Protein With Chromosome 14q Loss","ValueMeaning":{"publicId":"7992775","version":"1","preferredName":"Sonic Hedgehog Protein With Chromosome 14q Loss","longName":"7992775","preferredDefinition":"Sonic hedgehog protein (462 aa, ~50 kDa) is encoded by the human SHH gene. This protein plays a role in embryonic pattern formation.: Used to indicate the presence of something or someone.: One of the bodies in the cell nucleus that is the bearer of genes, has the form of a delicate chromatin filament during interphase, contracts to form a compact cylinder segmented into two arms by the centromere during metaphase and anaphase stages of cell division, and is capable of reproducing its physical and chemical structure through successive cell divisions.: Distal (long) arm of chromosome 14: A gradual decline in amount or activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sonic Hedgehog Protein","conceptCode":"C29962","definition":"Sonic hedgehog protein (462 aa, ~50 kDa) is encoded by the human SHH gene. This protein plays a role in embryonic pattern formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Chromosome","conceptCode":"C13202","definition":"A structure found in cells that is comprised of a strand of linearized double-stranded DNA plus proteins that package the DNA in a condensed coil form and regulate chromosomal function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"14q","conceptCode":"C13538","definition":"Distal (long) arm of chromosome 14","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Loss","conceptCode":"C25559","definition":"A gradual decline in amount or activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4293EA1-5600-0EBF-E053-4EBD850A1329","latestVersionIndicator":"Yes","beginDate":"2021-12-27","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-12-27","modifiedBy":"ONEDATA","dateModified":"2021-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4293EA1-5619-0EBF-E053-4EBD850A1329","beginDate":"2021-12-27","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-12-27","modifiedBy":"ONEDATA","dateModified":"2021-12-27","deletedIndicator":"No"},{"value":"SHH with GLI2 amplification","valueDescription":"Sonic Hedgehog Protein With GLI2 Gene Amplification","ValueMeaning":{"publicId":"7992776","version":"1","preferredName":"Sonic Hedgehog Protein With GLI2 Gene Amplification","longName":"7992776","preferredDefinition":"Sonic hedgehog protein (462 aa, ~50 kDa) is encoded by the human SHH gene. This protein plays a role in embryonic pattern formation.: Used to indicate the presence of something or someone.: This gene is involved in transcriptional regulation and plays a role in sonic hedgehog signal transduction.: Addition of extra material.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sonic Hedgehog Protein","conceptCode":"C29962","definition":"Sonic hedgehog protein (462 aa, ~50 kDa) is encoded by the human SHH gene. This protein plays a role in embryonic pattern formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"GLI2 Gene","conceptCode":"C18422","definition":"This gene is involved in transcriptional regulation and plays a role in sonic hedgehog signal transduction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Amplification","conceptCode":"C25418","definition":"Addition of extra material.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4293EA1-5628-0EBF-E053-4EBD850A1329","latestVersionIndicator":"Yes","beginDate":"2021-12-27","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-12-27","modifiedBy":"ONEDATA","dateModified":"2021-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4293EA1-5641-0EBF-E053-4EBD850A1329","beginDate":"2021-12-27","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-12-27","modifiedBy":"ONEDATA","dateModified":"2021-12-27","deletedIndicator":"No"},{"value":"SHH with p53 mutation","valueDescription":"Sonic Hedgehog Protein With TP53 Gene Mutation Abnormality","ValueMeaning":{"publicId":"7992777","version":"1","preferredName":"Sonic Hedgehog Protein With TP53 Gene Mutation Abnormality","longName":"7992777","preferredDefinition":"Sonic hedgehog protein (462 aa, ~50 kDa) is encoded by the human SHH gene. This protein plays a role in embryonic pattern formation.: Used to indicate the presence of something or someone.: This gene plays a critical role in cell cycle regulation and has tumor suppressor activity.: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sonic Hedgehog Protein","conceptCode":"C29962","definition":"Sonic hedgehog protein (462 aa, ~50 kDa) is encoded by the human SHH gene. This protein plays a role in embryonic pattern formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"TP53 Gene","conceptCode":"C17359","definition":"This gene plays a critical role in cell cycle regulation and has tumor suppressor activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4293EA1-5650-0EBF-E053-4EBD850A1329","latestVersionIndicator":"Yes","beginDate":"2021-12-27","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-12-27","modifiedBy":"ONEDATA","dateModified":"2021-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4293EA1-5669-0EBF-E053-4EBD850A1329","beginDate":"2021-12-27","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-12-27","modifiedBy":"ONEDATA","dateModified":"2021-12-27","deletedIndicator":"No"},{"value":"SHH with MYCN amplification","valueDescription":null,"ValueMeaning":{"publicId":"10389020","version":"1","preferredName":"Sonic Hedgehog Protein With NMYC Gene Amplification","longName":"10389020v1.00","preferredDefinition":"Sonic hedgehog protein (462 aa, ~50 kDa) is encoded by the human SHH gene. This protein plays a role in embryonic pattern formation._Used to indicate the presence of something or someone._A molecular genetic abnormality indicating the presence of multiple copies of the MYCN gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sonic Hedgehog Protein","conceptCode":"C29962","definition":"Sonic hedgehog protein (462 aa, ~50 kDa) is encoded by the human SHH gene. This protein plays a role in embryonic pattern formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"NMYC Gene Amplification","conceptCode":"C36673","definition":"A molecular genetic abnormality indicating the presence of multiple copies of the MYCN gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-23D8-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-05-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-31","modifiedBy":"KUMMEROA","dateModified":"2022-05-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC1DD82-23DA-2FB8-E053-731AD00AE15F","beginDate":"2022-05-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-31","modifiedBy":"KUMMEROA","dateModified":"2022-05-31","deletedIndicator":"No"},{"value":"Group 3 with MYC amplification","valueDescription":null,"ValueMeaning":{"publicId":"10389021","version":"1","preferredName":"Medulloblastoma Group Three With MYC Gene Amplification","longName":"10389021v1.00","preferredDefinition":"A malignant, invasive embryonal neoplasm arising from the cerebellum or posterior fossa. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: classic medulloblastoma, large cell/anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, and medulloblastoma with extensive nodularity._Any number of entities (members) considered as a unit._A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one._Used to indicate the presence of something or someone._A molecular genetic abnormality indicating the presence of multiple copies of the MYC gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medulloblastoma","conceptCode":"C3222","definition":"A malignant, invasive embryonal neoplasm arising from the cerebellum or posterior fossa. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: classic medulloblastoma, large cell/anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, and medulloblastoma with extensive nodularity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Group","conceptCode":"C43359","definition":"Any number of entities (members) considered as a unit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Three","conceptCode":"C66834","definition":"A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"MYC Gene Amplification","conceptCode":"C36641","definition":"A molecular genetic abnormality indicating the presence of multiple copies of the MYC gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-23D9-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-05-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-31","modifiedBy":"KUMMEROA","dateModified":"2022-05-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC1DD82-23DB-2FB8-E053-731AD00AE15F","beginDate":"2022-05-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-31","modifiedBy":"KUMMEROA","dateModified":"2022-05-31","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2960880","version":"1","preferredName":"Ineligibility Reason","preferredDefinition":"The state or quality of being disqualified by law, rule, or provision.:An explanation of the cause of some phenomenon or action.","longName":"C40412:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ineligibility","conceptCode":"C40412","definition":"The state or quality of being disqualified by law, rule, or provision.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"788A8521-F513-5F2F-E040-BB89AD4349DC","latestVersionIndicator":"Yes","beginDate":"2009-11-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-11-17","modifiedBy":"ONEDATA","dateModified":"2009-11-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B83AB409-7E35-C2EA-E040-BB89AD431B57","latestVersionIndicator":"Yes","beginDate":"2012-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-05","modifiedBy":"LISU","dateModified":"2022-12-01","changeDescription":"Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[{"name":"RsnNtMecTpTP","type":"COG GDE Short Name","context":"CTEP"},{"name":"DCP","type":"USED_BY","context":"DCP"}],"ReferenceDocuments":[{"name":"Reason patient did not meet e","type":"Preferred Question Text","description":"Reason patient did not meet eligibility criteria:","url":null,"context":"COG"},{"name":"DCP AQuIP Question Text","type":"Alternate Question Text","description":"Reason NOT Eligible for Contact","url":null,"context":"DCP"},{"name":"DCP AQuIP Question Text 2","type":"Alternate Question Text","description":"Eligibility Criteria Not Met","url":null,"context":"DCP"},{"name":"COG CRF Text 001","type":"Alternate Question Text","description":"Reason why the patient did not meet the eligibility criteria:","url":null,"context":"COG"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"If reason is \"Other\", specify:","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Reason why the patient did not meet the eligibility criteria for ACNS1422:","url":null,"context":"COG"},{"name":"COG CRF Text 21","type":"Alternate Question Text","description":"Reason why the patient did not meet the eligibility criteria for ACNS2031:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B83AB409-7F4F-C2EA-E040-BB89AD431B57","latestVersionIndicator":"Yes","beginDate":"2012-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-05","modifiedBy":"SPRINGERL","dateModified":"2022-04-20","changeDescription":"Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}